SYNVISC-ONE (Hylan G-F 20) - Synovial fluid supplementation substance

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Pieejams no:

Sanofi-Aventis Australia Pty Ltd

Klase:

Class III

Ražojis:

Genzyme Corporation 1125 Pleasant View Terrace, Ridgefield, NJ, 07657 United States Of America

Ārstniecības joma:

44757 - Synovial fluid supplementation substance

Ārstēšanas norādes:

A sterile, nonpyrogenic, elastoviscous fluid containing hylan polycaccharide (Hylan polymer 8.0 mg/mL) hydrated in physiological saline. Synvisc-One is only intended for intra-articular use to treat pain associated with osteoarthritis of the knee.

Autorizācija statuss:

A

Autorizācija datums:

2009-02-09